Affordability is one of several factors consumers may consider when evaluating supplements in this category
Agnihothri RV, Courville AB, Linderman JD, et al
When initiating WEGOVY, consider reducing the dose of concomitantly administered insulin secretagogue (such as sulfonylureas) or insulin to reduce the risk of hypoglycemia [see Warnings and Precautions (5.4) and Adverse Reactions (6.1)]
In preclinical research, doses from 6 g/kg to 20 mg/kg caused no acute organ toxicity, and thorough mutagenicity, genotoxicity, and teratogenicity assays returned negative results
Progress in clinical research Diabetic retinopathy As a leading cause of vision loss in working-age adults, DR presents a major therapeutic challenge [61, 77]